Abreva 00135-0300
Generic: Docosanol
Product NDC
00135-0300- Manufacturer
- Haleon Us Holdings Llc
- Dosage Form
- Cream
- Route
- Topical
- Product Type
- Human Otc Drug
- Marketing Start
- March 25, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA208754
Active Ingredients
| Ingredient | Strength |
|---|---|
| Docosanol | 100 mg/g |
Packaging Options(2)
1 TUBE in 1 PACKAGE (0135-0300-01) / 2 g in 1 TUBE
2 TUBE in 1 PACKAGE (0135-0300-02) / 2 g in 1 TUBE